Iain Brown
Nessuna posizione attualmente
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Iain Michael Brown ricopre la posizione di Senior VP, Chief Financial & Accounting Officer presso Alkermes Plc. Nella sua carriera passata il signor Brown ha occupato la posizione di vicepresidente finanziario per Alkermes, Inc. e vicepresidente finanziario presso EMD Serono, Inc. Si è laureato presso l'Università di Bradford.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 26/02/2024 | 116 344 ( 0.07% ) | 3 M $ | 31/03/2024 |
Precedenti posizioni note di Iain Brown
| Società | Posizione | Fine |
|---|---|---|
| ALKERMES PLC | Director of Finance/CFO | 01/02/2024 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director of Finance/CFO | 16/09/2011 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Director of Finance/CFO | - |
Formazione di Iain Brown
| University of Bradford | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Borsa valori
- Insiders
- Iain Brown
